US 11414496
Anti-CD38 binding domains
granted A61KA61K2039/505A61P
Quick answer
US patent 11414496 (Anti-CD38 binding domains) held by Takeda Pharmaceutical Company Limited expires Mon Aug 11 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Takeda Pharmaceutical Company Limited
- Grant date
- Tue Aug 16 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Aug 11 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 21
- CPC classes
- A61K, A61K2039/505, A61P, A61P35/02, A61P35/04